-
Something wrong with this record ?
Reinforced aneurysmorrhaphy for true aneurysmal haemodialysis vascular access
S. Rokošný, P. Baláž, P. Wohlfahrt, D. Palouš, L. Janoušek,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Aneurysm diagnosis surgery MeSH
- Blood Vessel Prosthesis Implantation methods MeSH
- Renal Dialysis methods MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Graft Occlusion, Vascular surgery MeSH
- Vascular Patency physiology MeSH
- Reoperation methods MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Vascular Surgical Procedures methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVE: In 2008, a new technique of reinforced aneurysmorrhaphy with a polyester mesh tube for salvaging true aneurysmal arteriovenous (AV) haemodialysis access was described by us. In this study, the long-term patency and complication rates associated with this procedure were analysed, and the effect of reinforced aneurysmorrhaphy on high-flow vascular access was assessed. METHODS: This was a retrospective non-randomised study with prospectively collected data performed at a single centre. Patients with true aneurysmal haemodialysis AV access who underwent aneurysmorrhaphy with external mesh prosthesis between March 2007 and October 2012 were included. Clinical assessment and duplex ultrasound were performed preoperatively, 1, 3, and 12 months postoperatively, and annually thereafter. RESULTS: Data from 62 patients (median age 60 years, range 28-81 years; 63% men) were analysed. The commonest indication was high-flow vascular access associated with the risk of high output cardiac failure (24 patients, 39%). The mean follow-up time was 14.66 ± 12.80 months. Primary patency rates at 6 and 12 months were 86% and 79% respectively. Assisted primary patency rates at 6 and 12 months were 89% and 80% respectively. In 23 patients (96%) operated on for high-flow vascular access, decreased vascular access flow was observed after the procedure. The average flow reduction after aneurysmorrhaphy was 2,197 mL/minute. Postoperative bleeding and infection necessitating surgical revision occurred in three (4.8%) and three (4.8%) patients respectively. CONCLUSIONS: Reinforced aneurysmorrhaphy with an external mesh prosthesis is an effective method for treating true aneurysmal haemodialysis AV access, with excellent long-term patency and minimal complications due to infection.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14063720
- 003
- CZ-PrNML
- 005
- 20170220094352.0
- 007
- ta
- 008
- 140704s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejvs.2014.01.010 $2 doi
- 035 __
- $a (PubMed)24530180
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Rokošný, S $u Vascular and Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: slavomir.rokosny@ikem.cz.
- 245 10
- $a Reinforced aneurysmorrhaphy for true aneurysmal haemodialysis vascular access / $c S. Rokošný, P. Baláž, P. Wohlfahrt, D. Palouš, L. Janoušek,
- 520 9_
- $a OBJECTIVE: In 2008, a new technique of reinforced aneurysmorrhaphy with a polyester mesh tube for salvaging true aneurysmal arteriovenous (AV) haemodialysis access was described by us. In this study, the long-term patency and complication rates associated with this procedure were analysed, and the effect of reinforced aneurysmorrhaphy on high-flow vascular access was assessed. METHODS: This was a retrospective non-randomised study with prospectively collected data performed at a single centre. Patients with true aneurysmal haemodialysis AV access who underwent aneurysmorrhaphy with external mesh prosthesis between March 2007 and October 2012 were included. Clinical assessment and duplex ultrasound were performed preoperatively, 1, 3, and 12 months postoperatively, and annually thereafter. RESULTS: Data from 62 patients (median age 60 years, range 28-81 years; 63% men) were analysed. The commonest indication was high-flow vascular access associated with the risk of high output cardiac failure (24 patients, 39%). The mean follow-up time was 14.66 ± 12.80 months. Primary patency rates at 6 and 12 months were 86% and 79% respectively. Assisted primary patency rates at 6 and 12 months were 89% and 80% respectively. In 23 patients (96%) operated on for high-flow vascular access, decreased vascular access flow was observed after the procedure. The average flow reduction after aneurysmorrhaphy was 2,197 mL/minute. Postoperative bleeding and infection necessitating surgical revision occurred in three (4.8%) and three (4.8%) patients respectively. CONCLUSIONS: Reinforced aneurysmorrhaphy with an external mesh prosthesis is an effective method for treating true aneurysmal haemodialysis AV access, with excellent long-term patency and minimal complications due to infection.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a aneurysma $x diagnóza $x chirurgie $7 D000783
- 650 _2
- $a cévy - implantace protéz $x metody $7 D019917
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a okluze cévního štěpu $x chirurgie $7 D006083
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a dialýza ledvin $x metody $7 D006435
- 650 _2
- $a reoperace $x metody $7 D012086
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a průchodnost cév $x fyziologie $7 D014654
- 650 _2
- $a výkony cévní chirurgie $x metody $7 D014656
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Baláž, Peter $u Vascular and Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Surgery, Faculty Hospital Kralovske Vinohrady, 3rd Medical Faculty, Charles University, Prague, Czech Republic. $7 xx0057810
- 700 1_
- $a Wohlfahrt, P $u Centre for Cardiovascular Prevention of the First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic; Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; International Clinical Research Centre, St. Anne's University Hospital Brno, Czech Republic.
- 700 1_
- $a Palouš, D $u Radiodiagnostic and Interventional Radiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Janoušek, L $u Vascular and Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 773 0_
- $w MED00001653 $t European journal of vascular and endovascular surgery the official journal of the European Society for Vascular Surgery $x 1532-2165 $g Roč. 47, č. 4 (2014), s. 444-50
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24530180 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20170220094543 $b ABA008
- 999 __
- $a ok $b bmc $g 1031204 $s 862452
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 47 $c 4 $d 444-50 $i 1532-2165 $m European journal of vascular and endovascular surgery $n Eur J Vasc Endovasc Surg $x MED00001653
- LZP __
- $a Pubmed-20140704
